Why uterine transplantation requires us to rethink the role of the pre-conception welfare principle [0.03%]
为何子宫移植需要我们重新思考孕前福利原则的作用
Laura O&#x;Donovan
Laura O&#x;Donovan
Uterine transplantation (UTx) is a programme of treatment aimed at providing a unique solution to absolute uterine factor infertility, enabling patients to have children as a result of their own pregnancies. As a transplant procedure perfor...
Value choices in European COVID-19 vaccination schedules: how vaccination prioritization differs from other forms of priority setting [0.03%]
欧洲新冠疫苗接种计划中的价值选择：疫苗优先次序与其他形式的优先次序有何不同
Karolina Wiśniowska,Tomasz Żuradzki,Wojciech Ciszewski
Karolina Wiśniowska
With the limited initial availability of COVID-19 vaccines in the first months of 2021, decision-makers had to determine the order in which different groups were prioritized. Our aim was to find out what normative approaches to the allocati...
On CAR-Ts, decentralized in-house models, and the hospital exception. Routes for sustainable access to innovative therapies [0.03%]
关于CAR-T、去中心化的内部模型以及医院例外情况。创新疗法的可持续获取途径
Luca Arnaudo
Luca Arnaudo
Chimeric Antigen Receptor T cells, or CAR-Ts, are a novel class of gene and cell 'one-shot' therapies based upon collecting, reprogramming, and using patients' own immune cells to treat their cancer. The article discusses the status, prospe...
Martin Zieger
Martin Zieger
The fast evolution of genetic sequencing techniques led to new applications in forensic genetics, one of these being the prediction of the physical appearance of a possible perpetrator from biological traces found at the crime scene. Some E...
Ethicolegal considerations of screening for brain injury in women who have experienced intimate partner violence [0.03%]
针对遭受伴侣暴力妇女进行脑部损伤筛查的伦理法律问题考虑
Quinn Boyle,Judy Illes,Deana Simonetto et al.
Quinn Boyle et al.
The vast majority of women who experience physical intimate partner violence (IPV) will likely suffer a brain injury (BI) as a result of the abuse. Accurate screening of IPV-BI can ensure survivors have access to appropriate health care and...
Addressing privacy risk in neuroscience data: from data protection to harm prevention [0.03%]
从数据保护到防止伤害：解决神经科学数据隐私风险
Anita S Jwa,Russell A Poldrack
Anita S Jwa
A recent increase in the amount and availability of neuroscience data within and outside of research and clinical contexts will enhance reproducibility of neuroscience research leading to new discoveries on the mechanisms of brain function ...
Biological patent thickets and delayed access to biosimilars, an American problem [0.03%]
专利密集阻碍生物仿制药的进入：一个美国的问题
Rachel Goode,Bernard Chao
Rachel Goode
Our study seeks to determine whether patent thickets covering biologic drugs are responsible for delayed biosimilar market entry. We compare patent assertions against the same biosimilar drugs across three countries. On average nine to twel...
The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders [0.03%]
自主人工智能的监管：护士执业者作为医师助手的经验教训
Walker Morrell,Carmel Shachar,Anthony P Weiss
Walker Morrell
The development of autonomous artificial intelligence (A-AI) products in health care raises novel regulatory challenges, including how to ensure their safety and efficacy in real-world settings. Supplementing a device-centered regulatory sc...
An ethico-legal assessment of intellectual property rights and their effect on COVID-19 vaccine distribution: an Australian case study [0.03%]
一项伦理法律评估：知识产权对COVID-19疫苗分配的影响——以澳大利亚为例
James Scheibner,Jane Nielsen,Dianne Nicol
James Scheibner
This article posits that Australia, as an affluent country with increasing capacity to manufacture vaccines, has an obligation to assist its regional (and global) counterparts in implementing vaccination programs that protect their populati...
Skating the line between general wellness products and regulated devices: strategies and implications [0.03%]
介于普通保健产品和受监管器械之间的滑冰线：策略及影响分析
David A Simon,Carmel Shachar,I Glenn Cohen
David A Simon
Health technology is advancing at a rapid clip, with many of these technologies appearing on consumer products like smartphones and tablets. Federal regulators have responded to these changes with a flexible approach that allows firms to ma...